Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda R Panfil

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Frontiers in Microbiology|January 9, 2019
CRISPR/Cas9 Genome Editing to Disable the Latent HIV-1 ProvirusAmanda R Panfil, James A London, Patrick L Green, et al.
Journal of Virology|February 4, 2025
YTHDF1 and YTHDC1 m<sup>6</sup>A reader proteins regulate HTLV-1 <i>tax</i> and <i>hbz</i> activityEmily M King, Amanda Midkiff, Karsyn McClain, et al.
Journal of Virology|May 17, 2013
The B-cell-specific transcription factor and master regulator Pax5 promotes Epstein-Barr virus latency by negatively regulating the viral immediate early protein BZLF1Ryan M Raver, Amanda R Panfil, Stacy R Hagemeier, et al.
Pathogens (Basel, Switzerland)|June 28, 2023
Upregulation of Neuropilin-1 Inhibits HTLV-1 InfectionWesley Kendle, Kimson Hoang, Erica Korleski, et al.
Frontiers in Microbiology|February 23, 2023
The PRMT5 inhibitor EPZ015666 is effective against HTLV-1-transformed T-cell lines <i>in vitro</i> and <i>in vivo</i>Kyle Ernzen, Corrine Melvin, Lianbo Yu, et al.
Frontiers in Microbiology|February 15, 2018
Stability of the HTLV-1 Antisense-Derived Protein, HBZ, Is Regulated by the E3 Ubiquitin-Protein Ligase, UBR5Amanda R Panfil, Jacob Al-Saleem, Cory M Howard, et al.
Cell Cycle (Georgetown, Tex.)|November 27, 2018
SAMHD1 inhibits epithelial cell transformation in vitro and affects leukemia development in xenograft miceKarthik M Kodigepalli, Minghua Li, Serena Bonifati, et al.
Journal of Virology|November 9, 2012
Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replicationCoral K Wille, Dhananjay M Nawandar, Amanda R Panfil, et al.
Frontiers in Immunology|August 12, 2022
HTLV-1 intragenic viral enhancer influences immortalization phenotype <i>in vitro</i>, but is dispensable for persistence and disease development in animal modelsVictoria Maksimova, Susan Smith, Jaideep Seth, et al.
Journal of Virology|January 29, 2016
Functional Comparison of HBZ and the Related APH-2 Protein Provides Insight into Human T-Cell Leukemia Virus Type 1 PathogenesisAmanda R Panfil, Nathan J Dissinger, Cory M Howard, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Frontiers in Microbiology|January 9, 2019
CRISPR/Cas9 Genome Editing to Disable the Latent HIV-1 ProvirusAmanda R Panfil, James A London, Patrick L Green, et al.
Journal of Virology|February 4, 2025
YTHDF1 and YTHDC1 m<sup>6</sup>A reader proteins regulate HTLV-1 <i>tax</i> and <i>hbz</i> activityEmily M King, Amanda Midkiff, Karsyn McClain, et al.
Journal of Virology|May 17, 2013
The B-cell-specific transcription factor and master regulator Pax5 promotes Epstein-Barr virus latency by negatively regulating the viral immediate early protein BZLF1Ryan M Raver, Amanda R Panfil, Stacy R Hagemeier, et al.
Pathogens (Basel, Switzerland)|June 28, 2023
Upregulation of Neuropilin-1 Inhibits HTLV-1 InfectionWesley Kendle, Kimson Hoang, Erica Korleski, et al.
Frontiers in Microbiology|February 23, 2023
The PRMT5 inhibitor EPZ015666 is effective against HTLV-1-transformed T-cell lines <i>in vitro</i> and <i>in vivo</i>Kyle Ernzen, Corrine Melvin, Lianbo Yu, et al.
Frontiers in Microbiology|February 15, 2018
Stability of the HTLV-1 Antisense-Derived Protein, HBZ, Is Regulated by the E3 Ubiquitin-Protein Ligase, UBR5Amanda R Panfil, Jacob Al-Saleem, Cory M Howard, et al.
Cell Cycle (Georgetown, Tex.)|November 27, 2018
SAMHD1 inhibits epithelial cell transformation in vitro and affects leukemia development in xenograft miceKarthik M Kodigepalli, Minghua Li, Serena Bonifati, et al.
Journal of Virology|November 9, 2012
Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replicationCoral K Wille, Dhananjay M Nawandar, Amanda R Panfil, et al.
Frontiers in Immunology|August 12, 2022
HTLV-1 intragenic viral enhancer influences immortalization phenotype <i>in vitro</i>, but is dispensable for persistence and disease development in animal modelsVictoria Maksimova, Susan Smith, Jaideep Seth, et al.
Journal of Virology|January 29, 2016
Functional Comparison of HBZ and the Related APH-2 Protein Provides Insight into Human T-Cell Leukemia Virus Type 1 PathogenesisAmanda R Panfil, Nathan J Dissinger, Cory M Howard, et al.
Pageof 4